{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:12:17Z","timestamp":1761513137349},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.lungcan.2012.04.016","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T03:01:53Z","timestamp":1337310113000},"page":"578-584","source":"Crossref","is-referenced-by-count":22,"title":["Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy"],"prefix":"10.1016","volume":"77","author":[{"given":"Seok-Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyeong-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Ji","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Yeong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Duk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Sil","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Yong","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lungcan.2012.04.016_bib0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jjco\/hyn026","article-title":"Cancer control activities in the Republic of Korea","volume":"38","author":"Yoo","year":"2008","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.lungcan.2012.04.016_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4143\/crt.2011.43.1.1","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008","volume":"43","author":"Jung","year":"2011","journal-title":"Cancer Res Treat"},{"issue":"Suppl. 1","key":"10.1016\/j.lungcan.2012.04.016_bib0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1634\/theoncologist.13-S1-28","article-title":"Considerations for second-line therapy of non-small cell lung cancer","volume":"13","author":"Stinchcombe","year":"2008","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.lungcan.2012.04.016_bib0020","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1378\/chest.111.6.1710","article-title":"Revisions in the international system for staging lung cancer","volume":"111","author":"Mountain","year":"1997","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.lungcan.2012.04.016_bib0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","article-title":"Cancer statistics, 2002","volume":"52","author":"Jemal","year":"2002","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.lungcan.2012.04.016_bib0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lungcan.2012.04.016_bib0035","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1200\/JCO.2000.18.1.122","article-title":"Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer","volume":"18","author":"Sandler","year":"2000","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.lungcan.2012.04.016_bib0040","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1200\/JCO.1998.16.7.2459","article-title":"Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study","volume":"16","author":"Wozniak","year":"1998","journal-title":"J Clin Oncol"},{"issue":"1\u20132","key":"10.1016\/j.lungcan.2012.04.016_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0027-5107(01)00142-7","article-title":"Recognition of cisplatin adducts by cellular proteins","volume":"478","author":"Kartalou","year":"2001","journal-title":"Mutat Res"},{"key":"10.1016\/j.lungcan.2012.04.016_bib0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.ge.29.120195.000441","article-title":"DNA repair in humans","volume":"29","author":"Sancar","year":"1995","journal-title":"Annu Rev Genet"},{"issue":"9","key":"10.1016\/j.lungcan.2012.04.016_bib0055","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.dnarep.2007.02.010","article-title":"Common XPD (ERCC2) polymorphisms have no measurable effect on nucleotide excision repair and basal transcription","volume":"6","author":"Laine","year":"2007","journal-title":"DNA Repair"},{"issue":"4","key":"10.1016\/j.lungcan.2012.04.016_bib0060","first-page":"604","article-title":"Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans","volume":"58","author":"Shen","year":"1998","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.lungcan.2012.04.016_bib0065","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1245\/s10434-011-1601-y","article-title":"DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy","volume":"18","author":"Ott","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.lungcan.2012.04.016_bib0070","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1158\/1078-0432.CCR-10-2169","article-title":"ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis","volume":"17","author":"Yin","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"24","key":"10.1016\/j.lungcan.2012.04.016_bib0075","first-page":"8654","article-title":"A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer","volume":"61","author":"Park","year":"2001","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.lungcan.2012.04.016_bib0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bjc.6603290","article-title":"Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy","volume":"95","author":"Sakano","year":"2006","journal-title":"Br J Cancer"},{"issue":"13","key":"10.1016\/j.lungcan.2012.04.016_bib0085","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","article-title":"XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy","volume":"22","author":"Gurubhagavatula","year":"2004","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.lungcan.2012.04.016_bib0090","first-page":"859","article-title":"Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers","volume":"10","author":"Yao","year":"2009","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5576","key":"10.1016\/j.lungcan.2012.04.016_bib0095","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"},{"issue":"6968","key":"10.1016\/j.lungcan.2012.04.016_bib0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The International HapMap Project","volume":"426","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2012.04.016_bib0105","first-page":"179","article-title":"Automated genotyping using the DNA MassArray technology","volume":"187","author":"Jurinke","year":"2002","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.lungcan.2012.04.016_bib0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ng1100","article-title":"Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots","volume":"33","author":"Phillips","year":"2003","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.lungcan.2012.04.016_bib0115","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"issue":"6945","key":"10.1016\/j.lungcan.2012.04.016_bib0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature01746","article-title":"Xpd\/Ercc2 regulates CAK activity and mitotic progression","volume":"424","author":"Chen","year":"2003","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.lungcan.2012.04.016_bib0125","first-page":"1354","article-title":"Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients","volume":"61","author":"Spitz","year":"2001","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.lungcan.2012.04.016_bib0130","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s11033-010-0258-0","article-title":"Effects of selected genetic polymorphisms in xeroderma pigmentosum complementary group D on gastric cancer","volume":"38","author":"Chen","year":"2011","journal-title":"Mol Biol Rep"},{"issue":"2","key":"10.1016\/j.lungcan.2012.04.016_bib0135","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","article-title":"A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer","volume":"91","author":"Stoehlmacher","year":"2004","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2012.04.016_bib0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.critrevonc.2005.01.005","article-title":"Predicting drug response and toxicity based on gene polymorphisms","volume":"54","author":"Robert","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8\u20139","key":"10.1016\/j.lungcan.2012.04.016_bib0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000086499","article-title":"Pharmacogenetics in gastrointestinal tumors","volume":"28","author":"Stohlmacher","year":"2005","journal-title":"Onkologie"},{"issue":"2","key":"10.1016\/j.lungcan.2012.04.016_bib0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ctrv.2004.12.006","article-title":"Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy","volume":"31","author":"Kweekel","year":"2005","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.lungcan.2012.04.016_bib0155","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1158\/1078-0432.CCR-07-1364","article-title":"Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine\/cisplatin-treated advanced non-small cell lung cancer patients","volume":"14","author":"Tibaldi","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.lungcan.2012.04.016_bib0160","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1158\/1078-0432.CCR-08-2715","article-title":"Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population","volume":"15","author":"Wu","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.lungcan.2012.04.016_bib0165","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1002\/cncr.21885","article-title":"Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer","volume":"106","author":"Booton","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2012.04.016_bib0170","first-page":"739","article-title":"Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751","volume":"12","author":"Li","year":"2011","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500212002152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500212002152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T17:33:50Z","timestamp":1561743230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500212002152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0169500212002152"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2012.04.016","relation":{},"ISSN":["0169-5002"],"issn-type":[{"type":"print","value":"0169-5002"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}